Laurence Blavier

3.3k total citations
21 papers, 1.7k citations indexed

About

Laurence Blavier is a scholar working on Cancer Research, Molecular Biology and Neurology. According to data from OpenAlex, Laurence Blavier has authored 21 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 11 papers in Molecular Biology and 8 papers in Neurology. Recurrent topics in Laurence Blavier's work include Protease and Inhibitor Mechanisms (8 papers), Neuroblastoma Research and Treatments (7 papers) and Peptidase Inhibition and Analysis (4 papers). Laurence Blavier is often cited by papers focused on Protease and Inhibitor Mechanisms (8 papers), Neuroblastoma Research and Treatments (7 papers) and Peptidase Inhibition and Analysis (4 papers). Laurence Blavier collaborates with scholars based in United States, Belgium and Denmark. Laurence Blavier's co-authors include Yves A. DeClerck, Jean‐Marie Delaissé, Hiroyuki Shimada, Sonata Jodele, Patrick Henriet, Suzan Imren, Janet Yoon, Michael T. Engsig, Thomas Levin Andersen and Kim Henriksen and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Journal of Cell Science.

In The Last Decade

Laurence Blavier

20 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurence Blavier United States 17 830 779 757 207 181 21 1.7k
Michaela Nathrath Germany 24 689 0.8× 647 0.8× 392 0.5× 236 1.1× 218 1.2× 70 1.8k
Zofia von Marschall Germany 20 848 1.0× 609 0.8× 398 0.5× 243 1.2× 111 0.6× 26 1.6k
Natacha Entz‐Werlé France 19 588 0.7× 428 0.5× 426 0.6× 138 0.7× 137 0.8× 83 1.5k
Akishi Ooi Japan 32 1.1k 1.3× 1.6k 2.0× 482 0.6× 217 1.0× 107 0.6× 86 3.0k
J Lawry United Kingdom 21 482 0.6× 469 0.6× 238 0.3× 212 1.0× 74 0.4× 45 1.4k
Riitta Alitalo Finland 25 1.5k 1.8× 885 1.1× 450 0.6× 331 1.6× 143 0.8× 52 2.5k
Caj Haglund Finland 26 616 0.7× 800 1.0× 371 0.5× 90 0.4× 76 0.4× 52 1.6k
Maria Serena Benassi Italy 29 922 1.1× 654 0.8× 580 0.8× 134 0.6× 119 0.7× 76 2.2k
Michael D. Oberst Germany 29 1.1k 1.3× 473 0.6× 380 0.5× 296 1.4× 94 0.5× 77 2.7k
H.-J. Terpe Germany 21 679 0.8× 486 0.6× 189 0.2× 158 0.8× 113 0.6× 34 1.4k

Countries citing papers authored by Laurence Blavier

Since Specialization
Citations

This map shows the geographic impact of Laurence Blavier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Blavier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Blavier more than expected).

Fields of papers citing papers by Laurence Blavier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Blavier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Blavier. The network helps show where Laurence Blavier may publish in the future.

Co-authorship network of co-authors of Laurence Blavier

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence Blavier. A scholar is included among the top collaborators of Laurence Blavier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence Blavier. Laurence Blavier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blavier, Laurence, Rebekah Kennedy, G. Esteban Fernández, et al.. (2024). Nuclear factor-κB activation by transforming growth factor-β1 drives tumour microenvironment-mediated drug resistance in neuroblastoma. British Journal of Cancer. 131(1). 90–100. 7 indexed citations
2.
Blavier, Laurence, Rie Nakata, Paolo Neviani, et al.. (2023). The capture of extracellular vesicles endogenously released by xenotransplanted tumours induces an inflammatory reaction in the premetastatic niche. Journal of Extracellular Vesicles. 12(5). e12326–e12326. 23 indexed citations
3.
Porras, Tania B., Sakunthala Muthugounder, Rebekah Kennedy, et al.. (2022). Fibroblasts and macrophages cooperate to create a pro-tumorigenic and immune resistant environment via activation of TGF-β/IL-6 pathway in neuroblastoma. OncoImmunology. 11(1). 2146860–2146860. 32 indexed citations
4.
Blavier, Laurence, et al.. (2020). The Tumor Microenvironment in Neuroblastoma: New Players, New Mechanisms of Interaction and New Perspectives. Cancers. 12(10). 2912–2912. 50 indexed citations
5.
Wu, Hongwei, Michael A. Sheard, Jemily Malvar, et al.. (2019). Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer Cells. Clinical Cancer Research. 25(15). 4761–4774. 57 indexed citations
6.
Borriello, Lucia, Rie Nakata, Michael A. Sheard, et al.. (2017). Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells. Cancer Research. 77(18). 5142–5157. 146 indexed citations
7.
Blavier, Laurence, Sanjeev K. Baniwal, Baruch Frenkel, et al.. (2015). Interaction between bone marrow stromal cells and neuroblastoma cells leads to a VEGFA-mediated osteoblastogenesis. International Journal of Cancer. 137(4). 797–809. 13 indexed citations
8.
Bergfeld, Scott A., Laurence Blavier, & Yves A. DeClerck. (2014). Bone Marrow–Derived Mesenchymal Stromal Cells Promote Survival and Drug Resistance in Tumor Cells. Molecular Cancer Therapeutics. 13(4). 962–975. 54 indexed citations
9.
Blavier, Laurence, et al.. (2010). Stromelysin-1 (MMP-3) is a target and a regulator of Wnt1-induced epithelial-mesenchymal transition (EMT). Cancer Biology & Therapy. 10(2). 198–208. 39 indexed citations
10.
Jodele, Sonata, Laurence Blavier, Janet Yoon, & Yves A. DeClerck. (2006). Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer and Metastasis Reviews. 25(1). 35–43. 168 indexed citations
11.
Blavier, Laurence, et al.. (2006). Matrix Metalloproteinases Play an Active Role in Wnt1-Induced Mammary Tumorigenesis. Cancer Research. 66(5). 2691–2699. 53 indexed citations
12.
Jodele, Sonata, Christophe Chantrain, Laurence Blavier, et al.. (2005). The Contribution of Bone Marrow–Derived Cells to the Tumor Vasculature in Neuroblastoma Is Matrix Metalloproteinase-9 Dependent. Cancer Research. 65(8). 3200–3208. 120 indexed citations
13.
Delaissé, Jean‐Marie, et al.. (2003). Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microscopy Research and Technique. 61(6). 504–513. 246 indexed citations
14.
Blavier, Laurence, et al.. (2001). TGF-β3-induced Palatogenesis Requires Matrix Metalloproteinases. Molecular Biology of the Cell. 12(5). 1457–1466. 139 indexed citations
15.
Henriet, Patrick, Laurence Blavier, & Yves A. DeClerck. (1999). Tissue inhibitors of metalloproteinases (TEMP) in invasion and proliferation. Apmis. 107(1-6). 111–119. 93 indexed citations
16.
Blavier, Laurence, Patrick Henriet, Suzan Imren, & Yves A. DeClerck. (1999). INHIBITION OF MATRIX METALLOPROTEINASES THERAPEUTIC APPLICATIONS. Annals of the New York Academy of Sciences. 878(1). 108–119. 84 indexed citations
17.
Blavier, Laurence & Yves A. DeClerck. (1997). Tissue inhibitor of metalloproteinases-2 is expressed in the interstitial matrix in adult mouse organs and during embryonic development.. Molecular Biology of the Cell. 8(8). 1513–1527. 47 indexed citations
18.
Imren, Suzan, Donald B. Kohn, Hiroyuki Shimada, Laurence Blavier, & Yves A. DeClerck. (1996). Overexpression of tissue inhibitor of metalloproteinases-2 retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion.. PubMed. 56(13). 2891–5. 115 indexed citations
19.
Blavier, Laurence & Jean‐Marie Delaissé. (1995). Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. Journal of Cell Science. 108(12). 3649–3659. 181 indexed citations
20.
Blavier, Laurence, et al.. (1960). [The surgical treatment of Parkinson's disease].. PubMed. 15. 73–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michaela Nathrath Breakdown of academic impact, for papers by Zofia von Marschall Breakdown of academic impact, for papers by Natacha Entz‐Werlé Breakdown of academic impact, for papers by Akishi Ooi Breakdown of academic impact, for papers by J Lawry Breakdown of academic impact, for papers by Riitta Alitalo Breakdown of academic impact, for papers by Caj Haglund Breakdown of academic impact, for papers by Maria Serena Benassi Breakdown of academic impact, for papers by Michael D. Oberst Breakdown of academic impact, for papers by H.-J. Terpe
Rankless by CCL
2026